The comeback continues. Professional journal advertising climbed in first-half 2011, driven by new and mature products. Marc Iskowitz on the biggest advertisers and most advertised brands
ImpactRx, which measures the impact of promotion on prescriber behavior, said it acquired 100% of TargetRx, a pharma sales and marketing effectiveness firm.
Oral anticoagulant Eliquis (apixaban) has demonstrated superior efficacy and bleeding profile to standard warfarin therapy. Barring any bombshells, that should be enough for this agent, being developed by Pfizer and Bristol-Myers Squibb, to get US approval and form a compelling sales narrative in the warfarin-alternative market, analysts say.
He takes a very direct approach to the pursuit of prostate health. He’s Branko the Prostate Czech, and he’s been wielding his latex glove to raise awareness during September’s Prostate Cancer Awareness Month.
Double the number of MDs used Google (87%) for professional research online as the next most-used search options (WebMD and PubMed, each at 43%), data from a recent survey show.